Medicinal product regulation and product liability in Finland: Overview

Thomson Reuters’ Practical Law Life Sciences Global Guide 2021

Posted on

18 Mar

2021

Share this

Dittmar & Indrenius > Insight > Medicinal product regulation and product liability in Finland: Overview

A Q&A guide to medicinal product regulation and product liability law in Finland.

The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability. The Q&A is part of the Thomson Reuters’ Global Guide to Life Sciences law.

Read the Finland chapter we contributed.

Share this